Vertex Pharmaceuticals
Search results
Jun 26, 2024 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.
From cancer research to prenatal screening to food safety, the applications are as universal as life itself. Learn More. Our goal is to transform human health by applying innovative genomics technologies to the analysis of genetic variation and function.
New sequencing technologies and capabilities will accelerate the genomic discoveries and clinical insights needed to transform human health. Revolutionary NovaSeq X Series sets new benchmark for speed, scale, accuracy, and sustainability.
Illumina | 470,415 followers on LinkedIn. Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic ...
View All. Maximize the effectiveness of your Illumina system, train new employees, or learn the latest techniques and best practices. We offer support webinars, online courses, expert video tips, and instructor-led trainings. Find Support Webinars and Online Training. Find Instructor-Led and Other Training.
A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome.
Sep 29, 2022 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced multiple breakthrough sequencing innovations at its inaugural Illumina Genomics Forum: The launch of NovaSeq™ 6000 Dx as the first FDA-registered and CE-marked in vitro diagnostic (IVD) high-throughput sequencer ...
Reach out for information about our products and services or get answers to questions about our technology. *For in vitro diagnostic use. Contact an Illumina representative for regional availability. Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.
